Skip to main content

Table 3 Preliminary data on baseline patients' characteristics

From: Design and implementation of the canadian kidney disease cohort study (CKDCS): A prospective observational study of incident hemodialysis patients

 

Cohort patients, N(%)

N

1074

Age*

62 (50, 73)

Male

662 (62)

Race

1074

   White

813 (76)

   Aboriginal

81 (8)

   East Asian

47 (4)

   South Asian

42 (4)

   Other

91 (8)

Marital status

937

   Married

581 (62)

   Single

163 (17)

   Divorced

104 (11)

   Widow

89 (9)

BMI, kg/m 2 *

26 (22, 31)

Cause of ESRD

916

   Diabetic nephropathy

380 (41.5)

   Glomerulonephritis

154 (16.8)

   Hypertensive/ischemic renal disease

68 (7.4)

   Polycystic kidney disease

49 (5.3)

   Other

265 (28.9)

Comorbidity

 

Arrhythmia

214 (20.9)

Cancer

156 (14.4)

Cerebrovascular disease

130 (12.7)

Congestive heart failure

202 (20.2)

Chronic lung disease

125 (12.7)

Claudication

131 (13.3)

Coronary disease

481 (46.7)

Dementia

28 (2.8)

Diabetes mellitus

515 (50.7)

Diabetic retinopathy

224 (23)

HBV

30 (2.9)

HCV

39 (3.8)

HIV

2 (.2)

Hypertension

785 (86.5)

Pericarditis

27 (2.7)

Peripheral neuropathy

239 (24.2)

Peripheral vascular disease

209 (20.6)

Prior cardiac arrest

20 (2)

Psychiatric illness

148 (15)

Seizure disorder

34 (3.4)

ECG

310 (28.7)

   Normal

61 (5.6)

   Abnormal

142 (13.1)

   No result

107 (9.9)

ECHO

320 (29.6)

   Normal

14 (1.3)

   Abnormal

50 (4.6)

   No result

256 (23.7)

Current Smoker

154 (15.7)

CLINICAL MANAGEMENT

 

Satellite HD unit€

201 (18.7)

Type of access

510

   AVF

138 (27.1)

   PTFE

10 (2)

   Non tunnel CVC

42 (8.2)

   Tunnel CVC

308 (60.4)

LABORATORY MEASURES*

 

Albumin, g/L

34 (30, 37)

Calcium, mmol/L

2.2 (2, 2.3)

Calcium X phosphate, mmol2/L2

3.6 (2.9, 4.5)

Creatinine, μmol/L

534 (424, 682)

Ferritin, μg/L

252 (136, 472)

Hemoglobin, g/L

99 (89, 109)

Phosphate, mmol/L

1.6 (1.2, 1.9)

PTH, pmol/L

26.2 (10.7, 45.8)

Transaturation, %

24 (17, 31)

Urea, mmol/L

18.6 (14.6, 23.5)

Kt/V

1.4 (1.2, 1.7)

Distance to Nephrologist, km

482

≤50

387 (80.3)

51 - 100

43 (8.9)

101 - 200

30 (6.2)

> 200

33 (6.8)

  1. *Median (interquartile range)
  2. €all clinics outside of Edmonton, Calgary and Vancouver considered satellite unit
  3. HD Hemodialysis; BMI body mass index; ESRD end-stage renal disease; HBV Hepatitis B virus; HCV Hepatitis C virus; HIV Human immunodeficiency virus; ECG electrocardiogram; ECHO echocardiogram; AVF Arterial Venous Fistula; PD Peritoneal dialysis; PTFE Polytetrafluoroethylene; CVC Central venous catheters; PTH parathyroid hormone